"Pre-targeted radioimmunotherapy: Validation of methods for radiolabeling of DOTA-biotin with Indium-111 and Yttrium-90" by J. Velez

Selected Works of John M. Pagel, MD, PhD

Follow Contact

Article

Pre-targeted radioimmunotherapy: Validation of methods for radiolabeling of DOTA-biotin with Indium-111 and Yttrium-90

The Journal of Nuclear Medicine (2010)

J. Velez
C. Thostenson
D. Hamlin, University of Washington
D. Scott Wilbur, University of Washington
John Pagel, Fred Hutchinson Cancer Research Center
Ajay Gopal, Seattle Cancer Care Alliance
Oliver Press, Fred Hutchinson Cancer Research Center
Joseph Rajendran, University of Washington Medical Center

Link

Disciplines

Materials Science and Engineering and
Nuclear

Publication Date

May 1, 2010

Citation Information

J. Velez, C. Thostenson, D. Hamlin, D. Scott Wilbur, et al.. "Pre-targeted radioimmunotherapy: Validation of methods for radiolabeling of DOTA-biotin with Indium-111 and Yttrium-90" The Journal of Nuclear Medicine Vol. 51 Iss. supplement 2 1472 (2010) p. 1472
Available at: http://works.bepress.com/john-pagel/195/